Format
Sort by
Items per page

Send to

Choose Destination

Best matches for microrna or mirna:

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Rupaimoole R et al. Nat Rev Drug Discov. (2017)

An overview of microRNAs. Hammond SM et al. Adv Drug Deliv Rev. (2015)

Intra-articular injection of microRNA-140 (miRNA-140) alleviates osteoarthritis (OA) progression by modulating extracellular matrix (ECM) homeostasis in rats. Si HB et al. Osteoarthritis Cartilage. (2017)

Search results

Items: 1 to 20 of 86565

1.

Optimizing Synthetic miRNA Minigene Architecture for Efficient miRNA Hairpin Concatenation and Multi-target Gene Knockdown.

Rousset F, Salmon P, Bredl S, Cherpin O, Coelho M, Myburgh R, Alessandrini M, Perny M, Roccio M, Speck RF, Senn P, Krause KH.

Mol Ther Nucleic Acids. 2018 Dec 14;14:351-363. doi: 10.1016/j.omtn.2018.12.004. [Epub ahead of print]

PMID:
30665184
2.

Nucleotide Modification Alters MicroRNA-Dependent Silencing of MicroRNA Switches.

Lockhart J, Canfield J, Mong EF, VanWye J, Totary-Jain H.

Mol Ther Nucleic Acids. 2018 Dec 18;14:339-350. doi: 10.1016/j.omtn.2018.12.007. [Epub ahead of print]

PMID:
30665183
3.

Posttranscriptional Regulation of 14q32 MicroRNAs by the CIRBP and HADHB during Vascular Regeneration after Ischemia.

Downie Ruiz Velasco A, Welten SMJ, Goossens EAC, Quax PHA, Rappsilber J, Michlewski G, Nossent AY.

Mol Ther Nucleic Acids. 2018 Dec 6;14:329-338. doi: 10.1016/j.omtn.2018.11.017. [Epub ahead of print]

PMID:
30665182
4.

Identification of microRNAs and their targets responding to low-potassium stress in two barley genotypes differing in low-K tolerance.

Zeng J, Ye Z, He X, Zhang G.

J Plant Physiol. 2019 Jan 16;234-235:44-53. doi: 10.1016/j.jplph.2019.01.011. [Epub ahead of print]

PMID:
30665047
5.

Association of purinergic receptor P2RX7 gene polymorphisms with depression symptoms.

Vereczkei A, Abdul-Rahman O, Halmai Z, Nagy G, Szekely A, Somogyi A, Faludi G, Nemoda Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 18. pii: S0278-5846(18)30729-2. doi: 10.1016/j.pnpbp.2019.01.006. [Epub ahead of print]

PMID:
30664971
6.

MicroRNA signature changes during induction of neural stem cells from human mesenchymal stem cells.

Venkatesh K, Kumari A, Sen D.

Nanomedicine. 2019 Jan 18. pii: S1549-9634(19)30014-0. doi: 10.1016/j.nano.2019.01.003. [Epub ahead of print]

PMID:
30664947
7.

The Role of microRNAs in Spinocerebellar Ataxia Type 3.

Krauss S, Evert BO.

J Mol Biol. 2019 Jan 18. pii: S0022-2836(19)30028-2. doi: 10.1016/j.jmb.2019.01.019. [Epub ahead of print] Review.

PMID:
30664869
8.

Mesenchymal stem cells in psoriatic lesions affect the skin microenvironment through circular RNA.

Liu R, Chang W, Li J, Cheng Y, Dang E, Yang X, Wang Q, Wang G, Li X, Zhang K.

Exp Dermatol. 2019 Jan 21. doi: 10.1111/exd.13890. [Epub ahead of print]

PMID:
30664808
9.

Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Jan 21. doi: 10.1038/s41564-018-0334-0. [Epub ahead of print]

PMID:
30664667
10.

In vivo miRNA delivery in whitefish: Synthetic MiR92b-3p uptake and the efficacy of gene expression silencing.

Brzuzan P, Woźny M, Lewczuk B, Florczyk M, Gomułka P, Budzińska P, Wesołowski M, Dobosz S.

Exp Biol Med (Maywood). 2019 Jan 21:1535370218824573. doi: 10.1177/1535370218824573. [Epub ahead of print]

PMID:
30664358
11.

MiR-744-3p regulates keratinocyte proliferation and differentiation via targeting KLLN in psoriasis.

Wang C, Zong J, Li Y, Wang X, Du W, Li L.

Exp Dermatol. 2019 Jan 21. doi: 10.1111/exd.13888. [Epub ahead of print]

PMID:
30664260
12.

Upregulation of miR‑33b promotes endometriosis via inhibition of Wnt/β‑catenin signaling and ZEB1 expression.

Zhang H, Li G, Sheng X, Zhang S.

Mol Med Rep. 2019 Jan 17. doi: 10.3892/mmr.2019.9870. [Epub ahead of print]

PMID:
30664209
13.

β‑elemene inhibits oxygen‑induced retinal neovascularization via promoting miR‑27a and reducing VEGF expression.

Zhang W, Chen L, Geng J, Liu L, Xu L.

Mol Med Rep. 2019 Jan 15. doi: 10.3892/mmr.2019.9863. [Epub ahead of print]

PMID:
30664207
14.

Global pathway view analysis of microRNA clusters in myasthenia gravis.

Bo C, Wang J, Zhang H, Cao Y, Lu X, Wang T, Wang Y, Li S, Kong X, Sun X, Liu Z, Ning S, Wang L.

Mol Med Rep. 2019 Jan 10. doi: 10.3892/mmr.2019.9845. [Epub ahead of print]

PMID:
30664201
15.

MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway.

Guo L, Bai Y, Ji S, Ma H.

Int J Oncol. 2019 Jan 17. doi: 10.3892/ijo.2019.4689. [Epub ahead of print]

PMID:
30664191
16.

MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1.

Zhang L, Zhang T, Deng Z, Sun L.

Oncol Rep. 2019 Jan 16. doi: 10.3892/or.2019.6971. [Epub ahead of print]

PMID:
30664185
17.

miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells.

Han T, Wu N, Wang Y, Shen W, Zou J.

Int J Mol Med. 2019 Jan 21. doi: 10.3892/ijmm.2019.4070. [Epub ahead of print]

PMID:
30664182
18.

Expression profiles and potential functions of circular RNAs in extracellular vesicles isolated from radioresistant glioma cells.

Zhao M, Xu J, Zhong S, Liu Y, Xiao H, Geng L, Liu H.

Oncol Rep. 2019 Jan 18. doi: 10.3892/or.2019.6972. [Epub ahead of print]

PMID:
30664179
19.

MicroRNA‑601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3.

Song Y, He S, Zhuang J, Wang G, Ni J, Zhang S, Ye Y, Xia W.

Mol Med Rep. 2019 Jan 15. doi: 10.3892/mmr.2019.9857. [Epub ahead of print]

PMID:
30664174
20.

miR‑671‑3p is downregulated in non‑small cell lung cancer and inhibits cancer progression by directly targeting CCND2.

Yao Y, Zhou Y, Fu X.

Mol Med Rep. 2019 Jan 15. doi: 10.3892/mmr.2019.9858. [Epub ahead of print]

PMID:
30664171

Supplemental Content

Loading ...
Support Center